Insights

Technical analysis and firm news on R&D tax relief, written by the advisers who prepare the claims.

Read more

10 Jul 2026Sector spotlights

ERIS for pre-revenue biotech and medtech

MJ

Matthew Jones ACA CTA

Founder & Managing Director

Read more

8 Jul 2026Making a claim

Innovate UK grants and R&D tax relief together

MJ

Matthew Jones ACA CTA

Founder & Managing Director

Read more

7 Jul 2026Firm news

From brilliant science to big business: reflections from Climb26

LJ

Lisa James

Business & Marketing Director

Read more

3 Jul 2026Sector spotlights

CRO contracts and R&D tax relief: who owns the claim?

MJ

Matthew Jones ACA CTA

Founder & Managing Director

Read more

30 Jun 2026Sector spotlights

Robotics prototyping and technological uncertainty

MJ

Matthew Jones ACA CTA

Founder & Managing Director

Read more

29 Jun 2026Firm news

LimestoneGrey to join the 'From Brilliant Science to Big Business' panel at Climb26

LJ

Lisa James

Business & Marketing Director

Read more

24 Jun 2026Sector spotlights

When machine learning development qualifies as R&D

MJ

Matthew Jones ACA CTA

Founder & Managing Director

Read more

18 Jun 2026Sector spotlights

Clinical trial costs in R&D claims

MJ

Matthew Jones ACA CTA

Founder & Managing Director

Read more

20 May 2026Scheme changes & policy

HMRC's Targeted Advance Assurance pilot: how it works and who can use it

MJ

Matthew Jones ACA CTA

Founder & Managing Director